Moreover, because ATRA promotes APL promyeloblast differentiation, it leads to decreased RARa-driven expression of TF and decreased production of cancer procoagulant, further diminishing the procoagulant activity of APL [37,38,113,114]. Here, RARA is linked to acute promyelocytic leukemia.